Compare FTLF & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FTLF | CBUS |
|---|---|---|
| Founded | 2005 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Agricultural Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 134.1M | 121.1M |
| IPO Year | 2006 | 2017 |
| Metric | FTLF | CBUS |
|---|---|---|
| Price | $10.04 | $1.38 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $21.50 | $9.00 |
| AVG Volume (30 Days) | 27.6K | ★ 348.7K |
| Earning Date | 05-14-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 74.33 |
| EPS | ★ 0.17 | N/A |
| Revenue | ★ $21,744,000.00 | $3,639,000.00 |
| Revenue This Year | $45.76 | $112.72 |
| Revenue Next Year | $5.10 | $83.18 |
| P/E Ratio | $60.76 | ★ N/A |
| Revenue Growth | ★ 11.52 | N/A |
| 52 Week Low | $8.67 | $1.09 |
| 52 Week High | $20.98 | $4.19 |
| Indicator | FTLF | CBUS |
|---|---|---|
| Relative Strength Index (RSI) | 49.26 | 42.68 |
| Support Level | $8.79 | $1.21 |
| Resistance Level | $15.34 | $1.56 |
| Average True Range (ATR) | 0.83 | 0.11 |
| MACD | 0.17 | 0.03 |
| Stochastic Oscillator | 45.88 | 39.53 |
FitLife Brands Inc is a provider of proprietary nutritional supplements for health-conscious consumers. The company markets and sells its products under NDS, PMD, Siren labs, Core active, Metis nutrition, Isatori, and Biogenetic laboratories brand names. Its product portfolio consists of sports nutrition, energy, sports drink products, meal replacement products, and weight loss products. The firm derives its revenue from product sales. Its product categories include Natural & Organic Foods, Functional Foods, Natural & Organic Personal Care and Household Products, and Supplements.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.